Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 37 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

24%

9 trials in Phase 3/4

Results Transparency

11%

2 of 18 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 1
9(30.0%)
N/A
7(23.3%)
Phase 2
5(16.7%)
Phase 3
5(16.7%)
Phase 4
4(13.3%)
30Total
Phase 1(9)
N/A(7)
Phase 2(5)
Phase 3(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT05994742Phase 3Active Not Recruiting

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Role: collaborator

NCT04704830Phase 3Active Not Recruiting

R21/Matrix-M in African Children Against Clinical Malaria

Role: collaborator

NCT07362498Completed

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

Role: collaborator

NCT07248423Not ApplicableNot Yet Recruiting

Start Taking Action for Tuberculosis in Kids

Role: collaborator

NCT06566417Completed

Social Media as a Risk Tool for HIV Prevention Needs

Role: collaborator

NCT05959616Phase 1Recruiting

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Role: collaborator

NCT04878549Recruiting

Transcriptomic Responses for the Identification of Pathogens

Role: collaborator

NCT03489018Phase 4Completed

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Role: collaborator

NCT04056117Phase 1Completed

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Role: collaborator

NCT04280692Phase 1Suspended

Controlled Human Malaria Infection Transmission Model - Phase A

Role: collaborator

NCT03723460Recruiting

Passive Dietary Intake Assessment Study

Role: collaborator

NCT04059471Phase 4Completed

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine

Role: collaborator

NCT04158713Phase 3Completed

Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)

Role: collaborator

NCT02287480Phase 1Completed

VSV-ZEBOV Geneva Vaccine Trial

Role: collaborator

NCT04542473Phase 2Unknown

Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

Role: collaborator

NCT04553016Phase 1Unknown

A Study to Test Three Experimental HIV Vaccines in Healthy Adults.

Role: collaborator

NCT04297436Not ApplicableCompleted

Gonococcal Vaccine Study in Key Populations in Kenya

Role: collaborator

NCT05321641Not ApplicableUnknown

Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications

Role: lead

NCT04050566Unknown

Malaria Birth Cohort (MBC) in Agogo, Ghana

Role: collaborator

NCT03208725Unknown

Childhood Acute Illness and Nutrition Network

Role: collaborator